Fig. 1From: Kinetic modeling of 68Ga-PSMA-11 and validation of simplified methods for quantification in primary prostate cancer patientsPrimary prostate cancer patient (PSA 5.57 ng/mL) presenting an intense focal 68Ga-PSMA-11 uptake in the left lobe of the prostate (SUV 45–60 min: 13.27). MR T2-weighted image (a), averaged dynamic PET 45–60 min post-injection (b), PET/MR fused image (c), and whole-body maximum intensity projection of the pelvis (d)Back to article page